Therefore, apart from the influence of excessive GH and IGF-1, acromegaly patients also suffer from hyperprolactinemia and hypopituitarism, causing comorbidities and worsening their quality of life and prognosis (7, 9–11). Here, GH1 is linked to hypopituitarism.